CME Group Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CME Group Inc. on February 28, 2023, covering events occurring on February 23, 2023. The filing primarily addresses executive leadership transitions within the finance organization.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses on corporate governance rather than financial performance data.
Material Changes
- Executive Departure: John W. Pietrowicz will retire from his position as Chief Financial Officer effective April 1, 2023.
- Executive Appointment: Lynne Fitzpatrick will assume the role of Chief Financial Officer effective April 1, 2023.
- Transition Role: Mr. Pietrowicz will remain employed by the Company until December 31, 2023, serving as a Special Advisor.
Management Commentary and Outlook
Ms. Fitzpatrick, 44, has served as Senior Managing Director and Deputy Chief Financial Officer since February 2022. Prior to that, she led business development, mergers and acquisitions, CME Ventures, and corporate treasury functions since 2017. She has been with the company since 2006. As CFO, she will participate in the compensation program on terms commensurate with other executive officers at the Senior Managing Director level. The filing confirms no family relationships between Ms. Fitzpatrick and other executives or directors, and no related-party transactions are proposed.
Investor Verification Checklist
- Confirm the effective date of the CFO transition (April 1, 2023).
- Verify Ms. Fitzpatrick's tenure and prior roles within CME Group's finance and treasury functions.
- Review the terms of Mr. Pietrowicz's Special Advisor role through December 31, 2023.
- Check for any subsequent filings regarding compensation adjustments or related-party transactions.